Healthcare Small Cap Stocks
Healthcare, medical devices, and health IT small caps — companies innovating in diagnostics, treatment delivery, and healthcare administration at compelling valuations.
| Ticker | Company | Price | Mkt Cap | P/E | Rev. Growth | Upside |
|---|---|---|---|---|---|---|
| ENSG | Ensign Group | $179.85 -1.45% | $10.48B | 28.2x | 17.3% | 22.3% |
| VIAV | Viavi Solutions | $38.56 -0.46% | $9.51B | — | 52.5% | 59.3% |
| STVN | Stevanato Group | $22.37 +3.04% | $6.11B | 39.3x | 7.8% | 11% |
| TVTX | Travere Therapeutics | $64.46 -2.27% | $5.99B | — | 48.2% | 15% |
| MMSI | Merit Medical Systems | $90.27 -1.86% | $5.39B | 37.2x | 9.5% | 11.1% |
| NVST | Envista Holdings | $26.94 -2.32% | $4.33B | 46.5x | 7.1% | 13.5% |
| IRTC | iRhythm Technologies | $127.98 +2.59% | $4.22B | — | 20.1% | 38.2% |
| CLDX | Celldex Therapeutics | $39.94 -4.22% | $3.14B | — | -97% | 45.4% |
| ALHC | Alignment Healthcare | $12.93 +1.17% | $2.68B | 68.1x | 31.6% | 86.2% |
| ADMA | ADMA Biologics | $9.76 -2.89% | $2.19B | 13.9x | 15.9% | 74.2% |
| NVCR | NovoCure | $17.77 -2.36% | $2.07B | — | 15.6% | 52.8% |
| AGIO | Agios Pharmaceuticals | $33.63 -4.24% | $2.01B | — | 259.3% | 36% |
| XNCR | Xencor | $27.00 -1.89% | $2.01B | — | 17.5% | 7.4% |
| LMAT | LeMaitre Vascular | $82.32 -1.55% | $1.88B | 28.8x | 9.6% | 30% |
| OMCL | Omnicell | $35.50 -2.55% | $1.62B | 42.3x | 7.5% | 63% |
| TNDM | Tandem Diabetes Care | $22.57 -3.79% | $1.57B | — | 5.8% | 27.2% |
| CNMD | Conmed Corporation | $51.38 +0.25% | $1.54B | 27.8x | 0.3% | -11.4% |
| ATEC | Alphatec Holdings | $9.29 -4.72% | $1.43B | — | 15.1% | 69.9% |
| USPH | US Physical Therapy | $78.00 -1.53% | $1.16B | 458.8x | 8.5% | 21.8% |
| INMD | InMode | $14.92 -0.8% | $858.6M | 12.3x | 0% | 8.4% |
| HSTM | HealthStream | $28.59 +0.14% | $836M | 39.7x | 12.5% | 20.7% |
| EOLS | Evolent Health | $8.35 -2.91% | $551.5M | — | 21.2% | 79.6% |
| EMBC | Embecta Corp | $5.47 +0.92% | $309.9M | 3.7x | -8.1% | -26.9% |
| TMCI | Treace Medical Concepts | $4.46 -2.19% | $290.1M | — | -4.2% | 23.3% |
| AMWL | Amwell | $11.79 -4.92% | $197M | — | -26.6% | 8.6% |
| TELA | Tela Bio | $0.64 -1.19% | $28.7M | — | -4.5% | 228.5% |
| CTSO | Cytosorbents Corporation | $0.31 -12.61% | $19.6M | — | 0.2% | 663.4% |
Analysis and Context
This sector screener currently shows 27 stocks from the selected industry segment — updated daily. The average P/E ratio is 65.1x. The average revenue growth rate is 16.4%. Sectors move through cyclical phases strongly correlated with macro factors — interest rates, GDP growth, commodity prices, and regulatory environment all drive sector dynamics. Analysts see an average of 62.2% upside in these sector names. Compare metrics against the sector average to identify relative over- and undervaluations. Sector concentration increases portfolio risk — maintain adequate diversification across industries and business models.
Ready to invest?
Compare the best brokers for US and European stocks — fees, platforms and account types side by side.
Compare brokers →